HB 4457 prohibits pharmacy benefits managers (PBMs) from owning or controlling pharmacy licenses in Oklahoma. The State Board of Pharmacy must revoke licenses of violators after November 2026, though it may issue temporary licenses for rare, orphan, or limited-distribution drugs until September 2028. Pharmacies must notify patients of service changes by January 2027, and the Board must provide lists of compliant pharmacies. This law prevents conflicts of interest by restricting PBMs from owning pharmacies.
SB 1847 modifies Oklahoma's ADvantage Waiver Program, which provides Medicaid home- and community-based services. It creates an exception allowing individuals with cognitive impairments to qualify if they were already residing in an assisted living center contracted with the state when their impairment developed, and the center has a specific accommodation plan. This change directly affects adults with cognitive impairments who live in state-contracted assisted living facilities and developed their condition after moving in. The bill does not alter financial or age requirements but adjusts eligibility for this specific group. The exception applies to those meeting all three conditions outlined in the bill's new subsection B.
HB 4421 requires Oklahoma's Department of Human Services (DHS) to conduct a safety analysis within 24 hours when a child is suspected of being "drug-endangered" (e.g., due to fentanyl exposure or substance use by caregivers). It mandates drug screening - including mandatory fentanyl testing - for parents or caregivers when substance use is suspected, and allows DHS to seek court orders if consent is refused. The bill also creates a "Child Welfare Fentanyl Testing Revolving Fund" to cover testing costs and requires DHS to refer certain abuse/neglect cases to law enforcement. These provisions directly affect children in welfare cases, their caregivers, DHS staff, and local law enforcement agencies.
HB 2947 adds a new provider code in Oklahoma Medicaid for master's and doctoral-level behavioral health clinical interns. These interns - graduate students in nationally accredited programs - can provide services under the direct supervision of licensed behavioral health providers (like LPCs or LCSWs) while following all Medicaid documentation and training requirements. The bill directly affects interns seeking practical experience and licensed supervisors who will oversee their Medicaid-covered services. It expands Medicaid access to behavioral health care by formalizing intern participation in the state's Medicaid plan.
HB 3345 requires mandatory mental health, substance abuse, and risk screenings for individuals arrested on felony charges in Oklahoma after their initial court appearance. These screenings, conducted by certified professionals from the Department of Mental Health, must be shared with courts, prosecutors, defendants, and their attorneys. Results cannot be used as evidence in criminal trials unless the defendant waives this right, but may inform sentencing or diversion options. The law takes effect November 1, 2026.
HB 3645 amends Oklahoma's hospice care requirements to expand eligibility determination options when patients lack legal representatives. It allows hospice admission decisions by a licensed long-term care administrator (with 6 months oversight and two physician approvals), two physicians reviewing medical history, or a primary care physician managing care for six months. The bill maintains existing standards like 24/7 care, bereavement programs, and prohibitions on improper patient solicitation. It directly affects hospice providers and patients without appointed guardians, ensuring timely access to hospice services under defined criteria.
HB 3544 prohibits AI chatbots with human-like features (e.g., claiming sentience or seeking emotional bonds) from being available to minors under 18. It requires developers to implement age verification systems and offer alternative versions without such features for minors. Therapeutic chatbots providing mental health support are exempt if they include clear disclaimers, require professional oversight, provide clinical evidence of safety, and maintain transparency. Violations could result in civil penalties up to $7,500 per intentional violation, with minors or parents able to seek damages of $100-$750 per incident. The law takes effect November 1, 2026.
HB 3052 requires Oklahoma's Department of Human Services (DHS) to initiate a mandatory "enhanced child safety review" when a parent has two or more drug-exposed infants (born positive for drugs or with drug-positive mothers) within five years. This triggers DHS to notify qualified family members (like grandparents or aunts/uncles without abuse history) about safety planning and placement options, while hospitals must report drug-positive births to enable statewide tracking. The bill prevents DHS from withholding notification solely due to confidentiality concerns when child safety is at risk and explicitly prohibits criminalizing pregnancy or substance use disorder. It affects DHS, hospitals, courts, and families by mandating coordinated responses to prevent repeat harm, based on the case of Sir Major White-Bullock.
HB 3901 establishes a pilot program for psychological autopsies in Oklahoma, which investigate ambiguous deaths (like suicides) to reconstruct a deceased person's mental state and influences. The Commissioner of Health must appoint a full-time psychological autopsy examiner who will submit annual progress reports and coordinate with mental health and medical examiner offices. The pilot runs until November 1, 2031, with a recommendation for permanency or termination. Its goal is to use data from these reviews to inform suicide prevention efforts, without changing existing laws or creating new obligations for individuals.
HB 3587 allows Oklahoma courts to order outpatient mental health treatment instead of hospitalization for eligible individuals, prioritizing community-based care when it meets treatment needs and prevents harm to the person or others. The bill requires certified community mental health centers to develop treatment plans in collaboration with the individual, advocates, and their treatment team, which must be approved by the court. Courts must review these plans at least every 90 days through status hearings (with 72-hour notice), prohibit forced medication administration, and allow modifications or extensions if needed. This law directly affects individuals under court-ordered outpatient treatment and mental health providers, ensuring structured oversight while preserving patient rights.
